New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 15, 2014
07:01 EDTPBHPrestige Brands to acquire Hydralyte from The Hydration Pharmaceuticals Trust
Prestige Brands announced the signing of a purchase agreement for the acquisition of Hydralyte in Australia and New Zealand from The Hydration Pharmaceuticals Trust of Victoria, Australia. The acquisition is expected to close, subject to customary closing conditions, during 1Q115, which began on April 1. The acquisition is projected to double the annual revenues of Care Pharmaceuticals, Prestige’s subsidiary in Australia, to approximately A$50M for FY15, and is expected to be accretive to Prestige’s EPS for FY15, exclusive of transaction, integration and purchase accounting items. Prestige acquired Care Pharmaceuticals in July 2013. Financial terms of the acquisition have not been disclosed. Prestige funded this acquisition, its fifth in the past five years, with a combination of cash on the balance sheet and its existing credit facility with very minimal impact on the company’s leverage ratio or M&A capacity.
News For PBH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 23, 2015
06:40 EDTPBHPrestige Brands to host conference call
Subscribe for More Information
06:31 EDTPBHPrestige Brands agrees to acquire DenTek Holdings for $225M
Subscribe for More Information
November 12, 2015
10:25 EDTPBHPrestige Brands repeats view of FY16 adjusted EPS at high end of $2.05-$2.10
Consensus $2.11. Repeats call for FY16 revenue growth of 10%-11%, consensus $784.6M. Sees FY16 free cash flow of $175M or more. Guidance issued on November 5 repeated in slides for Raymond James Fall Investor Conference.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use